Tirzepatide was originally developed to treat Type-2 diabetes but has since become a leading anti-obesity medication. It is a dual agonist of the GLP-1 and GIP receptors — meaning it activates two distinct hormonal pathways to reduce appetite, improve metabolic rate, and support sustained weight loss.
Unlike its predecessor Semaglutide (which only targets GLP-1), Tirzepatide showed 5–7% more weight loss in clinical trials. Compared to Retatrutide, a triple agonist, Tirzepatide accomplished nearly the same weight loss but over a longer period (72 weeks vs. 48).
Mechanism of Action
- GLP-1: Suppresses appetite and increases feelings of fullness after eating.
- GIP: Promotes insulin secretion and supports energy balance through receptors in the hypothalamus.
Benefits
- Average weight loss of 24.7% after 72 weeks
- Reduces appetite and cravings
- Enhances satiety and energy balance
- Supports fat oxidation and metabolism
- Improves insulin sensitivity and blood sugar control
Possible Side Effects (often mild and temporary; affected only ~25% in trials)
- Injection site reaction (redness, swelling, itching)
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Decreased appetite
- Fatigue
- Dyspepsia (indigestion)
- Abdominal pain
- Burping (may have sulfur smell)
- Hair loss
Rare but serious risks
- Thyroid C-Cell Tumors
- Pancreatitis
- Gastroparesis (stomach paralysis)
- Hypoglycemia (if used with insulin)
- Gallbladder disease
- Kidney issues (linked to dehydration)
- Pulmonary aspiration under anesthesia – ALWAYS disclose Tirzepatide use to surgical teams
Contraindications
- Do not use if pregnant or breastfeeding
- Do not use with a personal or family history of Medullary Thyroid Carcinoma or MEN 2 (Multiple Endocrine Neoplasia)
- Do not use if you have Type-1 diabetes, diabetic retinopathy, or severe GI disease
- Do not use if you are allergic or hypersensitive to Tirzepatide
=================================================================================================
Stacking Suggestions
- AOD-9604 – enhances fat breakdown and further accelerates weight loss alongside appetite suppression
- Tesamorelin – synergistic for fat reduction, especially visceral fat and metabolic regulation
- Semax or Selank – manage mood and cognitive function while adjusting to appetite changes
- NAD+ or MOTS-C – support energy, mitochondrial efficiency, and metabolism while on a caloric deficit
- BPC-157 – beneficial for gut repair if experiencing nausea, indigestion, or stomach discomfort
- CJC-1295 / Ipamorelin – for muscle maintenance and enhanced metabolic recovery while losing fat
